Article
EGFR signaling and autophagy dependence for growth, survival, and therapy resistance
13 Dec 2013
Abstract excerpt
The epidermal growth factor receptor (EGFR) is amplified or mutated in various human epithelial tumors. Its expression and activation leads to cell proliferation, differentiation, and survival. Consistently, EGFR amplification or expression of EGFR variant 3 (EGFRvIII) is associated with resistance to conventional cancer therapy through activation of pro-survival signaling and DNA-repair mechanisms. EGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
